Table 4.
NK | CD3+CD56+ | CD56+ | CD8+CD56+ | CD8–CD56+ | CD3–CD8+ | CD56+ in CD3–CD8+ | CD56+ in CD3–CD8– | |
Peripheral blood | ||||||||
% | 3.28 ± 0.57 | 0.38 ± 0.10 | 0.10 ± 0.03 | 0.21 ± 0.07 | 0.03 ± 0.02 | 4.75 ± 0.49 | 2.77 ± 0.81 | 35.2 ± 6.3 |
No. of samples | 17 | 17 | 17 | 17 | 17 | 45 | 16 | 16 |
Spinal bone marrow | ||||||||
% | 5.85 ± 0.82 | 0.48 ± 0.12 | 5.78 ± 2.00 | 2.38 ± 1.00 | 4.33 ± 1.67 | 0.29 ± 0.09 | 14.20 ± 1.60 | 20.80 ± 6.10 |
No. of samples | 8 | 8 | 7 | 7 | 7 | 11 | 7 | 7 |
Ilial bone marrow | ||||||||
% | 4.94 ± 0.90 | 0.126 ± 0.095 | 5.01 ± 2.69 | 1.18 ± 1.14 | 4.25 ± 4.25 | 0.44 ± 0.27 | 5.47 ± 4.19 | 32.50 ± 6.20 |
No. of samples | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 |
Mesenteric lymph nodes | ||||||||
% | 0.65 ± 0.30 | 1.95 ± 1.23 | 2.96 ± 1.66 | 1.55 ± 0.92 | 2.22 ± 1.45 | 1.13 ± 0.95 | 9.82 ± 3.03 | 1.89 ± 0.90 |
No. of samples | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Spleen | ||||||||
% | 1.18 ± 0.38 | 0.53 ± 0.19 | 2.72 ± 0.80 | 1.31 ± 0.41 | 0.80 ± 0.44 | 3.70 ± 0.88 | 3.12 ± 0.98 | 3.64 ± 1.45 |
No. of samples | 6 | 6 | 6 | 6 | 6 | 10 | 6 | 6 |
Thymus (all cells) | ||||||||
% | 0.62 ± 0.34 | 0.65 ± 0.30 | 1.84 ± 0.66 | 1.84 ± 0.66 | 0.88 ± 0.38 | 23.0 ± 3.2 | 1.85 ± 0.72 | 3.13 ± 1.02 |
No. of samples | 10 | 10 | 9 | 9 | 9 | 9 | 9 | 8 |
Thymus (CD3+) | ||||||||
% | NA | NA | 2.64 ± 0.96 | 2.98 ± 0.84 | 1.32 ± 0.67 | NA | NA | NA |
No. of samples | NA | NA | 9 | 9 | 9 | NA | NA | NA |
Thymus (CD3low/negative) | ||||||||
% | NA | NA | 1.26 ± 0.80 | 1.38 ± 0.57 | 0.98 ± 0.58 | NA | NA | NA |
No. of samples | NA | NA | 9 | 9 | 9 | NA | NA | NA |
NA, not applicable